Home

MAX REINHARDT

CIK 1780058 · President, Global Spine · last filed 2026-03-06

MAX REINHARDT is a President, Global Spine who has filed 20 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider sold $27.2K of OFIX on Mar 6, 2026. Across all open-market trades the lifetime net is −$6.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.01M

Companies

2

Total Filings

20

Lifetime Open-Market Net

-$6.65M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OFIX President, Global Spine 25,348 $10.54 $267.2K -$46.3K 4 2026-03-06
PCRX President, Rest of World 30,324 $24.39 $739.6K -$6.61M 13 2023-06-07

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-06 OFIX Sell (S) −2,133 -$27.2K EDGAR
2025-06-13 OFIX Sell (S) −1,643 -$19.1K EDGAR
2025-03-05 OFIX Grant (A) +14,723 $0 EDGAR
2024-06-12 OFIX Grant (A) +14,401 $187.5K EDGAR
2023-06-12 PCRX Notice (144) −5,085 -$183.2K EDGAR
2023-06-07 PCRX Notice (144) −1,099 -$41.6K EDGAR
2023-06-07 PCRX Sell (S) −2,153 -$82.7K EDGAR
2023-06-06 PCRX Notice (144) −1,054 -$41.1K EDGAR
2022-10-11 PCRX Sell (S) −1,380 -$80.0K EDGAR
2022-06-08 PCRX Mixed +2,700 -$323.7K EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.